CARRIERI, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 11.261
EU - Europa 3.606
AS - Asia 3.562
SA - Sud America 866
Continente sconosciuto - Info sul continente non disponibili 400
AF - Africa 130
OC - Oceania 9
Totale 19.834
Nazione #
US - Stati Uniti d'America 11.052
SG - Singapore 1.401
IT - Italia 1.133
CN - Cina 813
BR - Brasile 701
DE - Germania 549
SE - Svezia 408
HK - Hong Kong 398
RU - Federazione Russa 344
VN - Vietnam 305
FR - Francia 290
GB - Regno Unito 242
UA - Ucraina 174
FI - Finlandia 141
BD - Bangladesh 125
IN - India 124
CA - Canada 97
ID - Indonesia 66
TR - Turchia 59
AR - Argentina 49
MX - Messico 44
IE - Irlanda 40
NL - Olanda 39
JP - Giappone 38
PL - Polonia 38
IQ - Iraq 37
BE - Belgio 35
CI - Costa d'Avorio 35
CO - Colombia 32
AT - Austria 27
ES - Italia 25
ZA - Sudafrica 25
PK - Pakistan 23
IR - Iran 22
SA - Arabia Saudita 22
CH - Svizzera 20
EC - Ecuador 20
PH - Filippine 19
VE - Venezuela 19
CZ - Repubblica Ceca 16
UZ - Uzbekistan 16
CL - Cile 15
LT - Lituania 15
CR - Costa Rica 14
MY - Malesia 14
JM - Giamaica 13
MA - Marocco 12
EG - Egitto 11
JO - Giordania 11
DK - Danimarca 10
KE - Kenya 10
PY - Paraguay 9
DZ - Algeria 7
EE - Estonia 7
KR - Corea 7
TN - Tunisia 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
AU - Australia 6
AZ - Azerbaigian 6
DO - Repubblica Dominicana 6
PE - Perù 6
RO - Romania 6
TH - Thailandia 6
BO - Bolivia 5
GE - Georgia 5
GT - Guatemala 5
KG - Kirghizistan 5
NI - Nicaragua 5
OM - Oman 5
RS - Serbia 5
TT - Trinidad e Tobago 5
BY - Bielorussia 4
GA - Gabon 4
HN - Honduras 4
LB - Libano 4
NG - Nigeria 4
NO - Norvegia 4
NP - Nepal 4
PT - Portogallo 4
SV - El Salvador 4
TW - Taiwan 4
BA - Bosnia-Erzegovina 3
HU - Ungheria 3
IL - Israele 3
LY - Libia 3
PR - Porto Rico 3
AO - Angola 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
ET - Etiopia 2
GR - Grecia 2
GY - Guiana 2
HR - Croazia 2
IS - Islanda 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
Totale 19.399
Città #
Dallas 2.480
Ashburn 954
Singapore 733
Fairfield 725
San Jose 641
Woodbridge 507
Chandler 505
Houston 399
Hong Kong 381
Jacksonville 357
Milan 343
Nyköping 298
Seattle 291
Council Bluffs 254
Cambridge 251
Wilmington 239
Ann Arbor 222
Beijing 193
Bari 167
Los Angeles 129
New York 128
Lauterbourg 116
Nanjing 113
Lawrence 107
Roxbury 107
Santa Clara 105
Boardman 97
Marseille 97
Rome 93
Dong Ket 84
Ho Chi Minh City 81
Brooklyn 72
Des Moines 64
São Paulo 63
Munich 59
Princeton 59
Hanoi 56
Chicago 50
Columbus 50
Washington 50
London 48
Helsinki 44
San Diego 44
Buffalo 41
Jakarta 41
Dublin 37
Figino 36
North Bergen 36
Abidjan 35
Tokyo 33
Brussels 32
Jiaxing 32
Warsaw 32
Frankfurt am Main 31
Inglewood 31
Atlanta 30
Nanchang 29
Phoenix 29
Orem 28
Turin 28
Amsterdam 27
Moscow 27
Toronto 26
Chennai 25
Denver 25
Rio de Janeiro 25
Falkenstein 23
Montreal 23
San Francisco 22
Shenyang 22
Nuremberg 21
Paris 20
Redwood City 19
Tianjin 19
Mumbai 18
Sannicandro di Bari 18
Boston 17
Guangzhou 17
Changsha 16
Dearborn 16
Naples 16
West Jordan 16
Belo Horizonte 15
Bologna 15
Hebei 15
Istanbul 15
Kansas City 14
Brasília 13
Johannesburg 13
Mexico City 13
Stockholm 13
Tashkent 13
Ankara 12
Manchester 12
Medellín 12
Delhi 11
Jeddah 11
Leawood 11
Pittsburgh 11
Shanghai 11
Totale 13.105
Nome #
1, 3‐Benzothiazoles as Antimicrobial Agents 1.141
1,2,3,4-Tetrahydroisoquinoline/2H-chromen-2-one conjugates as nanomolar P-glycoprotein inhibitors: Molecular determinants for affinity and selectivity over multidrug resistance associated protein 1 1.130
1,3-Benzothiazoles as Antimicrobial Agents 1.118
Probiotic and Tea Tree Oil Treatments Improve Therapy of Vaginal Candidiasis: A Preliminary Clinical Study 266
miRNAs for the Detection of MultiDrug Resistance: Overview and Perspectives 237
4H-1,4-benzothiazine, dihydro-1,4-benzothiazinones and 2-amino-5- fluorobenzenethiol derivatives: Design, synthesis and in vitro antimicrobial screening 235
Chasing ChEs-MAO B Multi-Targeting 4-Aminomethyl-7-Benzyloxy-2H-Chromen-2-ones 217
2-Aminobenzothiazole derivatives: Search for new antifungal agents 216
Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease 212
A convenient synthesis of lubeluzole and its enantiomer: Evaluation as chemosensitizing agents on human ovarian adenocarcinoma and lung carcinoma cells 195
Synthesis, in vitro evaluation, and molecular modeling investigation of benzenesulfonimide peroxisome proliferator-activated receptors α antagonists 191
Bioisosteric Modification of To042: Synthesis and Evaluation of Promising Use-Dependent Inhibitors of Voltage-Gated Sodium Channels 187
Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer’s Disease Agents 185
The chemosensitizing agent lubeluzole binds calmodulin and inhibits Ca2+/calmodulin-dependent Kinase II 183
Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors 179
,3-Benzothiazoles as Antimicrobial Agents 178
Structure-property relationship study of the HPLC enantio-selective retention of neuroprotective 7-[(1-alkylpiperidin-3-yl)methoxy]coumarin derivatives on an amylose-based chiral stationary phase 177
Effect of Methyl -β- Cyclodextrin on the antimicrobial activity of a new series of poorly water-soluble benzothiazoles 175
Involvement of I2-imidazoline binding sites in positive and negative morphine analgesia modulatory effects 174
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp 172
1,3,5-triazine derivatives as dual inhibitors of 5-HT6R/FAAH in search of new therapy for Alzheimer's disease 171
2-(2-Phenylcyclopropyl)-Imidazolines: Reversed Enantioselective Interaction At I1 and I2 Imidazoline Receptors 170
New tetrahydroisoquinoline-based P-glycoprotein modulators: Decoration of the biphenyl core gives selective ligands 163
Structure-Activity Relationship Studies on Tetrahydroisoquinoline Derivatives: [4′-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-ylmethyl)biphenyl-4-ol] (MC70) Conjugated through Flexible Alkyl Chains with Furazan Moieties Gives Rise to Potent and Selective Ligands of P-glycoprotein 158
Alpidem analogues containinig a GABA or glycine moiety as new anticonvulsant agents 154
Synthesis.and biological evaluation of pyridazino[4,3-b]indoles and indeno[1,2-c]pyridazines as new ligands of central and peripheral benzodiazepine receptors 154
Repositioning of Endonuclear Receptors Binders as Potential Antibacterial and Antifungal Agents. Eptyloxìm: A Potential and Novel Gyrase B and Cytochrome Cyp51 Inhibitor 153
Structural Determinants in the Binding of BB2 Receptor Ligands: In Silico, X-Ray and NMR Studies in PD176252 Analogues. 149
High Affinity Central Benzodiazepine Receptor Ligands. Part 2: Quantitative Structure-Activity Relationships and Comparative Molecular Field Analysis of Pyrazolo[4,3-c]quinolin-3-ones 145
Antifungal Biofilm Inhibitory Effects of Combinations of Diclofenac and Essential Oils 145
A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE) 144
Ligands of neuronal nicotinic acetylcholine receptor (nAChR): inferences from the Hansch and 3-D Quantitative Structure-Activity Relationship (QSAR) models 142
Coumarin, chromone, and 4(3H)-pyrimidinone novel bicyclic and tricyclic derivatives as antiplatelet agents: synthesis, biological evaluation, and comparative molecular field analysis 141
Lubeluzole: from anti-ischemic to chemosensitizing agent 141
Lipophilicity of teicoplanin antibiotics as assessed by reversed phase high-performance liquid chromatography: quantitative structure-property and structure-activity relationships 138
Investigation on platelet aggregation inhibitory activity by phenyl amides and esters of piperidinecarboxylic acids 137
3D-QSAR models and docking studies of reversible inhibitors of type A and B Monoamine Oxidases 136
Elucidation of the synergistic action of Mentha Piperita essential oil with common antimicrobials 136
Design, synthesis and biological evaluation of a class of bioisosteric oximes of the novel dual peroxisome proliferator-activated receptor alpha/gamma ligand LT175 133
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 133
2-D and 3-D modeling of imadazoline receptor ligands: insights into pharmacophore 133
Papain catalyzed hydrolysis of aryl esters: a comparison of the Hansch, Docking and CoMFA methods 129
Ligand binding to I2 imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models. 129
(contributo in convegno) MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY; CHEMOMETRIC ANALYSIS, DOCKINGS AND SITE-DIRECTED MUTAGENESIS OF DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS α/γ AGONISTS 129
Non-Antibiotic Drug Repositioning as an Alternative Antimicrobial Approach 128
Allyphenyline Analogues Potentially Useful in the Management of Chronic Pain and Opioid Addiction 127
Evaluation of water‐soluble Mannich base prodrugs of 2,3,4,5‐tetrahydroazepino[4,3‐b]indol‐1(6H)‐one as multitarget‐directed agents for Alzheimer’s disease 127
Chiral pyrrolidines as multipotent agents in Alzheimer and neurodegenerative diseases 125
Understanding of the MAO-A and B Reversible Inhibitory Activity and Selectivity by Using 3D Descriptors of Lipophilicity 125
MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY: CHEMOMETRIC ANALYSIS, DOCKINGS AND SITE-DIRECTED MUTAGENESIS OF DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS α/γ AGONISTS 123
The in silico insights of α-adrenergic receptors over the last decade: methodological approaches and structural features of the 3D models 123
Diffuse Intrinsic Pontine Glioma (DIPG): breakthrough and clinical perspective 122
Analisi conduttimetrica 121
Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer’s drug candidates 120
Guinea-pig ileum as ex vivo model useful to characterize ligands displaying Imidazoline I2 and Adrenergic alpha2 mixed activity: a preliminary study 119
alpha2-adrenoreceptors profile modulation and high antinociceptive activity of (S)-(-)-2-[1-(Biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole 119
Alpha2-adrenoreceptors profile modulation. 3.1 (R)-(+)-m-nitrobiphenyline, a new efficient and alpha2C-subtype selective agonist 119
Rational design of the new antihypertensive I1-receptor ligand 2-(2-biphenyl-2-yl-1-methyl-ethyl-)4,5-dihydro-1H-imidazole 119
Dioxane and oxathiane nuclei: suitable substructures for muscarinic agonists 119
Enhanced solubility and antibacterial activity of lipophilic fluoro-substituted N-benzoyl-2-aminobenzothiazoles by complexation with beta-cyclodextrins 118
Binding Models of Reversible Inhibitors to Monoamine Oxidases 117
High affinity central benzodiazepine receptor ligands: synthesis and structure-activity relationship studies of a new series of pyrazolo[4,3-c]quinolin-3-ones. 117
A twenty-year journey exploring coumarin-based derivatives as bioactive molecules 116
Natural and synthetic geiparvarins are strong and selective MAO-B inhibitors. Synthesis and SAR studies. 116
Neuronal Nicotinic Agonists: a Multi-approach Development of the Pharmacophore 116
Enhanced antibacterial efficacy of new benzothiazole phthalimide hybrid compounds/methyl--cyclodextrin inclusion complexes compared to the free forms: insights into the possible mode of action 112
High affinity central benzodiazepine receptor ligands II: QSAR studies and CoMFA analysis pyrazolo(4,3-c)quinolin-3-ones 112
alfa2-adrenoreceptors profile modulation. 2.1 Biphenyline analogues as tools for selective activation of alfa2C-subtype 110
Might the observed a2A-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations? 110
Novel Phenothiazine/Donepezil-Like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer’s Disease 109
Neuronal nicotinic receptor agonists: multi-approach pharmacophore development and 3D-QSAR predictive models, 107
Exploring the Antibiofilm Effect of Sertraline in Synergy with Cinnamomum verum Essential Oil to Counteract Candida Species 106
New molecular requirements of Toc derivatives bearing a novel class of Nav1.4 blockers 106
Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Ureidopropanamides as Formyl Peptide Receptor 2 (FPR2) Agonists to Target the Resolution of Inflammation in Central Nervous System Disorders 106
Conformationally constrained butyrophenones with mixed dopaminergic (D(2)) and serotoninergic (5-HT(2A), 5-HT(2C)) affinities: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo- and -thienocycloalkanones as putative atypical antipsychotics. 105
Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease 103
Novel 6-alkyl-bridged 4-arylalkylpiperazin-1-yl derivatives of azepino[4,3-b]indol-1(2H)-one as potent BChE-selective inhibitors showing protective effects against neurodegenerative insults 102
Modeling the structural basis of the human CCR5 chemokine receptor functions: from homology model-builiding and molecular dynamics validation to agonist and anatgonist docking 102
2D- and 3D-QSAR of tocainide and mexiletine analogues acting as Na(v)1.4 channel blockers 102
Binding models of reversible inhibitors to type-B monoamine oxidase 101
Sintesi alternativa del lubeluzolo e del suo enantiomero e valutazione come agenti in grado di potenziare l'effetto di farmaci antitumorali. 101
Enantiomeric Separation and Molecular Modelling of Bioactive 4-Aryl-3,4-dihydropyrimidin-2(1H)-one Ester Derivatives on Teicoplanin-Based Chiral Stationary Phase 101
Antibiofilm Effects of Plant Extracts Against Staphylococcus aureus 100
Pharmacophore development and 3D-QSAR study of I1 imidazoline binding site ligands 99
Molecular determinants for nuclear receptors selectivity: chemometric analysis, dockings and site-directed mutagenesis of dual peroxisome proliferator-activated receptors alpha/gamma agonists 99
Evaluation of the Potential Cytoprotective Effect of Melatonin in Comparison with Vitamin E and Trolox against Cd2+-Induced Toxicity in SH-SY5Y, HCT 116, and HepG2 Cell Lines 96
Linezolid hybrid analogs: synthesis and antimicrobial studies of oxalodinone-mercaptobenzothiazole compounds 96
Comparative Molecular Field Analysis of pyridawinone-containing alfa1-antagonists 96
Binding of tracizolines to the imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models 96
Benzothiazole-Phthalimide Hybrids as Anti-Breast Cancer and Antimicrobial Agents 94
Synergistic Action of Cinnamomum verum Essential Oil with Sertraline 92
Dimeric analogs of the dual PPARα/γ agonist LT-175: design, synthesis and biological evaluation. 90
Neuronal nicotinic receptor agonists: multi-approach pharmacophore development and 3D QSAR predictive models 90
SAR of Non-Nucleoside HIV-1 RT inhibitors (NNRTIs): Comparative Molecular field Analysis (CoMFA) and Docking Studies 89
Synthesis and biological screening of new chiral a-aryloxy-alkanoic acids as PPARs agonists 89
Recent Trends And Future Prospects In Computational GPCR Drug Discovery: From Virtual Screening To Polypharmacology. 85
Extended form of a retro-inverso peptide stabilized by beta-sheet unidirectional H-bonds: Crystallographic and NMR evidence 85
Scouting around 1,2,3,4-Tetrahydrochromeno[3,2-c]pyridin-10-ones for Single- and Multitarget Ligands Directed towards Relevant Alzheimer's Targets 85
Multiple causes, multiple targets: FAAH as a centerpiece for therapy of multifactorial pathologies. 85
N‑Aryl-2,6-dimethylbenzamides, a new generation of tocainide analogues as blockers of skeletal muscle voltage-gated sodium channels 84
Totale 16.212
Categoria #
all - tutte 70.590
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.590


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022692 0 0 0 41 22 48 49 44 56 84 134 214
2022/20231.556 220 141 93 125 183 190 14 155 337 22 40 36
2023/2024675 44 99 26 43 52 102 40 29 39 54 52 95
2024/20252.436 73 69 196 109 66 165 221 233 148 145 356 655
2025/20267.950 698 773 2.169 677 565 352 583 213 535 542 215 628
2026/20271.713 160 281 546 726 0 0 0 0 0 0 0 0
Totale 19.834